Tag Archives: arthritis

October, 2018

February, 2017

June, 2016

  • 15 June

    FDA Panel Scheduled to Review Amgen’s Humira Biosimilar

    THOUSAND OAKS, Calif., June 13, 2016 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data supporting the Company’s Biologics License Application (BLA) for ABP 501, a biosimilar candidate to Humira® (adalimumab). “With our heritage in both rheumatology …